Target Extracellular traps
| Zeile 1: | Zeile 1: | ||
| + | [Bibliography Extracellular Traps - HCQ| see related one-time-biliography] | ||
| + | |||
{{tp|p=32302401|t=2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps |pdf=|usr=}} | {{tp|p=32302401|t=2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps |pdf=|usr=}} | ||
{{tp|p=32355564|t=2020. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome |pdf=|usr=}} | {{tp|p=32355564|t=2020. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome |pdf=|usr=}} | ||
Version vom 10. August 2020, 07:32 Uhr
[Bibliography Extracellular Traps - HCQ| see related one-time-biliography]
32302401 2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps
32355564 2020. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
32505910 2020. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1beta/neutrophil extracellular traps feedback loop.
32534340 2020. The intriguing commonality of NETosis between COVID-19 & Periodontal disease.
| 32543703 2020. SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure. |
32597954 2020. Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome.
32581816 2020. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19.
